Your browser is no longer supported. Please, upgrade your browser.
Settings
GHDX Genomic Health, Inc. daily Stock Chart
GHDX [NASD]
Genomic Health, Inc.
Index- P/E- EPS (ttm)-0.20 Insider Own1.90% Shs Outstand36.36M Perf Week-7.06%
Market Cap1.92B Forward P/E64.55 EPS next Y0.82 Insider Trans-24.29% Shs Float33.88M Perf Month-1.71%
Income-6.80M PEG- EPS next Q0.09 Inst Own91.90% Short Float2.72% Perf Quarter39.29%
Sales349.40M P/S5.51 EPS this Y73.30% Inst Trans0.56% Short Ratio2.82 Perf Half Y60.64%
Book/sh6.34 P/B8.35 EPS next Y56.79% ROA1.80% Target Price32.42 Perf Year71.91%
Cash/sh4.21 P/C12.59 EPS next 5Y- ROE2.10% 52W Range26.54 - 59.49 Perf YTD54.77%
Dividend- P/FCF48.72 EPS past 5Y-19.50% ROI-4.20% 52W High-11.03% Beta0.40
Dividend %- Quick Ratio5.40 Sales past 5Y7.70% Gross Margin82.90% 52W Low99.43% ATR2.39
Employees863 Current Ratio5.40 Sales Q/Q11.80% Oper. Margin0.60% RSI (14)45.32 Volatility3.85% 4.79%
OptionableYes Debt/Eq0.00 EPS Q/Q384.70% Profit Margin1.20% Rel Volume1.26 Prev Close53.74
ShortableYes LT Debt/Eq0.00 EarningsAug 02 AMC Payout0.00% Avg Volume326.53K Price52.93
Recom2.90 SMA20-4.55% SMA500.55% SMA20039.14% Volume412,576 Change-1.51%
Jun-13-18Downgrade Ladenburg Thalmann Buy → Neutral
Dec-20-17Downgrade William Blair Outperform → Mkt Perform
Dec-13-17Downgrade JP Morgan Neutral → Underweight
May-03-17Downgrade Raymond James Outperform → Mkt Perform
Jan-18-17Initiated Deutsche Bank Hold $31
Feb-11-16Reiterated Canaccord Genuity Buy $44 → $38
Jan-11-16Downgrade Piper Jaffray Overweight → Neutral
Jan-07-16Reiterated Barclays Underweight $25 → $27
Jan-06-16Upgrade Canaccord Genuity Hold → Buy $26 → $44
Nov-23-15Upgrade UBS Neutral → Buy $29 → $38
Nov-04-15Upgrade Raymond James Mkt Perform → Outperform
Sep-02-15Initiated Barclays Underweight $25
Aug-28-15Upgrade Raymond James Underperform → Mkt Perform
Aug-05-15Reiterated Canaccord Genuity Hold $28 → $26
Mar-10-15Initiated UBS Neutral $34
Aug-11-14Reiterated Canaccord Genuity Hold $30 → $27
Aug-02-13Reiterated MLV & Co Hold $30 → $35
Feb-21-12Downgrade GARP Research Buy → Neutral
Feb-08-12Downgrade MLV & Co Buy → Hold $31.50 → $30
Dec-12-11Reiterated Ladenburg Thalmann Buy $26 → $32
Aug-13-18 01:39AM  Edited Transcript of GHDX earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-18 04:23PM  Genomic Health Starts Its Marathon Motley Fool
Aug-03-18 10:16AM  Genomic Health (GHDX) Q2 Earnings and Revenues Top Estimates Zacks
07:52AM  The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings Benzinga
Aug-02-18 07:50PM  Genomic Health (GHDX) Tops Q2 Earnings and Revenue Estimates Zacks
06:43PM  Genomic Health: 2Q Earnings Snapshot Associated Press
04:05PM  Genomic Health Announces Second Quarter 2018 Financial Results and Reports Recent Business Progress PR Newswire
02:30PM  Genomic Health, Inc. to Host Earnings Call ACCESSWIRE
08:54AM  The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter Benzinga
Jul-26-18 08:00AM  Genomic Health to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 2, 2018 PR Newswire
Jul-20-18 11:35AM  Lilly (LLY) Issues Update on Diabetes Drug Trulicity Label Zacks
10:05AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
09:28AM  Can the Rally in Genomic Health (GHDX) Shares Continue? Zacks
08:43AM  AVEO Pharmaceuticals (AVEO) Soars: Stock Adds 11.8% in Session Zacks
08:01AM  Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues Zacks
Jul-19-18 11:17AM  Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4 Zacks
09:24AM  Can Solid Global Prospects Drive Align's (ALGN) Q2 Earnings? Zacks
Jul-18-18 03:20PM  Abbott (ABT) Q2 Earnings & Revenues Top Estimates, View Up Zacks
Jul-17-18 09:50AM  Is Genomic Health (GHDX) Stock Outpacing Its Medical Peers This Year? Zacks
08:13AM  AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife Zacks
06:56AM  Veeva Systems' Development Cloud Platform Picked by Idorsia Zacks
Jul-16-18 10:45AM  J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay Zacks
07:45AM  Here's Why You Should Invest in DaVIta (DVA) Stock Right Now Zacks
Jul-11-18 11:05AM  Achillion's 3rd Factor D Inhibitor Enters Clinical Studies Zacks
Jul-10-18 01:16PM  Top Stock Picks for the Week of July 9th Zacks
10:40AM  Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle Zacks
Jul-06-18 09:02AM  Arbutus Biopharma (ABUS) Jumps: Stock Rises 9.6% Zacks
Jul-05-18 10:42AM  Insulet Omnipod Insulin Pump Finds Favor in British Columbia Zacks
Jul-04-18 06:50AM  Here's Why You Should Invest in Masimo (MASI) Right Now Zacks
Jul-03-18 09:28AM  Integer Holdings Offloads AS&O, Focuses on Cardiac Units Zacks
09:27AM  Insulet Banks on Omnipod's Growing Market Reach, Runs Risks Zacks
08:14AM  Brush Off Volatility Concerns With These 5 Low-Beta Stocks Zacks
Jul-02-18 09:08AM  Here's Why You Should Hold Wright Medical (WMGI) Stock Now Zacks
Jun-29-18 11:24AM  Pfizer's Leukemia Candidate Gets Priority Review From FDA Zacks
09:05AM  Thermo Fisher to Buy Gatan, Boost Electron Microscopy Suite Zacks
07:46AM  MOHAP Selects Masimo's (MASI) Eve for CCHD Screening in UAE Zacks
Jun-28-18 11:29AM  Walgreens (WBA) Tops Q3 Earnings Estimates, Narrows View Zacks
11:00AM  Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer PR Newswire
10:40AM  Stryker (SYK) to Acquire SafeAir, Reduce Surgical Smoke Zacks
09:30AM  Here's Why You Should Steer Clear of Fresenius Medical Now Zacks
Jun-27-18 11:32AM  Agios Out-Licenses China Rights to Leukemia Drug Tibsovo Zacks -5.31%
11:08AM  Align Scripts New Success in EMEA, Lifts Global Progress Zacks
10:07AM  Patterson's (PDCO) NaVetor Launch to Boost Animal Health Unit Zacks
09:07AM  Integra LifeSciences Global Prospects Solid, Competition Rife Zacks
Jun-26-18 11:00AM  Pra Health Grows Organically, Symphony Synergies a Positive Zacks
10:45AM  Here's Why You Must Add STERIS (STE) to Your Portfolio Now Zacks
Jun-25-18 11:43AM  IDEXX Laboratories Global Growth Solid on Catalyst Uptake Zacks
08:36AM  Here's Why You Should Hold Merit Medical (MMSI) Stock Now Zacks
Jun-22-18 10:37AM  Why You Should Retain Quest Diagnostics in Your Portfolio Zacks
Jun-21-18 10:35AM  Paratek's Antibiotic Candidate Gets FDA Committee Date Zacks
08:49AM  Array BioPharma (ARRY) Looks Good: Stock Adds 5.2% in Session Zacks
Jun-20-18 10:08AM  Amgen Gets EU Nod to Add Survival Data on Blincyto's Label Zacks
08:44AM  REGENXBIO (RGNX) in Focus: Stock Moves 6.2% Higher Zacks
Jun-19-18 08:25AM  Research Report Identifies Synaptics, Ethan Allen Interiors, Urban Edge Properties, RPM International, Genomic Health, and United Community Banks with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jun-18-18 08:46AM  BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5% Zacks
08:23AM  ISRG or ITGR: Which is a Better Medical Instrument Stock? Zacks
Jun-15-18 08:50AM  Here's Why You Should Sell Patterson Companies Stock Now Zacks
08:30AM  Wright Medical Gets FDA PMA for AUGMENT Injectable, Shares Up Zacks
Jun-14-18 11:37AM  PetMed (PETS) Optimistic About New Orders Amid Cost Woes Zacks
11:33AM  Medtronic ActivaProgramming Application Wins FDA Nod for DBS Zacks
Jun-13-18 10:28AM  Idera Stock Down, Study on Dermatomyositis Candidate Fails Zacks
09:15AM  Cardinal Health to Gain From FDA Panel Vote for INCRAFT PMA Zacks
Jun-07-18 11:07AM  Why You Should Add IDEXX (IDXX) Stock to Your Portfolio? Zacks
10:32AM  Here's Why You Should Invest in Genomic Health (GHDX) Now Zacks
10:20AM  ABMD or VAR: Which is a Better Medical Instrument Stock? Zacks
Jun-06-18 03:28PM  Varian to Demonstrate Brachytherapy Solutions Portfolio Zacks
Jun-05-18 09:46AM  Company News For Jun 5, 2018 Zacks
09:30AM  Here's Why You Should Sell Accuray (ARAY) Stock Right Now Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Genomic Health and Immunomedics ACCESSWIRE
Jun-04-18 03:47PM  Some breast cancer patients may not need chemotherapy, depending on their genes Quartz +23.07%
01:58PM  Here's Why Genomic Health Rocketed Higher Today Motley Fool
09:28AM  McKesson (MCK) Acquires Medical Specialties for $800 million Zacks
09:26AM  Morgan Stanley Calls Labs 'Safe Havens': Stocks to Watch Zacks
Jun-03-18 07:56AM  [$$] Breast cancer study set to free women from chemotherapy Financial Times
07:30AM  Many women with early-stage breast cancer can skip chemotherapy-study Reuters
07:30AM  Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Breast Cancer Who Receive No Benefit from Chemotherapy, and the 30% of Women for Whom Chemotherapy Benefit Can be Life-saving PR Newswire
Jun-01-18 08:53AM  PRA Health (PRAH) Up 0.2% in a Month Post Mixed Q1 Earnings Zacks
08:46AM  vTv Therapeutics (VTVT) Catches Eye: Stock Jumps 6.9% Zacks
May-30-18 08:00AM  Genomic Health to Present at Jefferies 2018 Global Healthcare Conference PR Newswire
May-29-18 09:58AM  Bio-Rad (BIO) Up 13.5% in 3 Weeks Post Solid Q1 Earnings Zacks
08:00AM  Merchavia Reports Positive Results in a Breakthrough Trial for Early Prostate Cancer Diagnosis PR Newswire
May-24-18 04:23PM  Intuitive Surgical (ISRG) Gains on Strength in Robotics Zacks
May-23-18 11:00AM  Here's Why You Should Buy Cooper Companies (COO) Stock Now Zacks
May-22-18 10:42AM  Allscripts Acquires HealthGrid to Improve Patient Outcome Zacks
May-21-18 08:19AM  Cerner-VA Pact to Use EHR Platform for Better Veteran Service Zacks
08:00AM  New Data Reinforce Positive Impact of the Oncotype DX® Genomic Prostate Score Test in Guiding Treatment Decisions PR Newswire
May-18-18 09:55AM  Varian Medical (VAR) Merges With Brazil MOH to Fight Cancer Zacks
09:42AM  Here's Why You Should Steer Clear of Cerner (CERN) for Now Zacks
08:50AM  Here's Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now Zacks
08:44AM  Weakness Seen in Anika Therapeutics (ANIK) Estimates: Should You Stay Away? Zacks
May-17-18 11:23AM  Thermo Fisher (TMO) Gains on Latest Buyouts Despite Cost Woes Zacks
10:28AM  Abaxis (ABAX) to be Acquired by Zoetis, Shares All-Time High Zacks
09:15AM  Veeva Systems Launches Veeva Nitro, Boosts MedTech Analytics Zacks
May-16-18 09:58AM  Can The Uptrend Continue for Genomic Health (GHDX)? Zacks
May-15-18 09:35AM  Baxter (BAX) Gets FDA Nod for Spectrum IQ, Secures Infusions Zacks
May-14-18 11:00AM  Here's Why You Should Sell Fresenius Medical (FMS) Stock Now Zacks
May-11-18 09:16AM  Here's Why You Should Invest in Varian Medical (VAR) Now Zacks
May-10-18 10:10AM  Here's Why You Should Invest in Intuitive Surgical Right Now Zacks
May-09-18 08:00AM  Genomic Health to Present at Bank of America Merrill Lynch 2018 Health Care Conference PR Newswire
04:38AM  Edited Transcript of GHDX earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions worldwide. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company offers the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the breast cancer recurrence and chemotherapy benefit. It also provides the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer; the Oncotype DX prostate cancer test, which provides a genomic prostate score to predict disease aggressiveness in men with low risk disease, as well as used to enhance treatment decisions for prostate cancer patients in conjunction with the Gleason score or tumor grading; and Oncotype DX AR-V7 Nucleus Detect test for men with metastatic castration-resistant prostate cancer. The company offers its products through a network of distributors. Genomic Health, Inc. has collaboration agreement with Epic Sciences, Inc.; license and development agreement with Biocartis N.V.; license agreement with Cleveland Diagnostics, Inc.; and a research collaboration agreement with Janssen Pharmaceuticals. The company was founded in 2000 and is based in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shak StevenChief Scientific OfficerAug 09Option Exercise17.335,50095,315342,241Aug 10 06:47 PM
Pla FredericChief Bus & Prod Dev OfficerAug 09Option Exercise27.001,50040,50041,038Aug 10 06:45 PM
Cole G BradleyCOOAug 09Option Exercise17.188,529146,52853,901Aug 10 06:41 PM
Cole G BradleyCOOAug 09Sale55.948,529477,10545,372Aug 10 06:41 PM
Shak StevenChief Scientific OfficerAug 09Sale55.925,500307,576336,741Aug 10 06:47 PM
Pla FredericChief Bus & Prod Dev OfficerAug 09Sale55.935,500307,62535,538Aug 10 06:45 PM
Radford Jason W.Chief Legal OfficerAug 08Sale56.394,126232,68134,050Aug 10 06:36 PM
Cohen Fred EDirectorAug 07Option Exercise25.798,250212,76875,572Aug 09 07:47 PM
Cohen Fred EDirectorAug 07Sale56.228,250463,80067,322Aug 09 07:47 PM
GRAHAM GINGER LDirectorAug 06Option Exercise17.3316,500285,94526,756Aug 08 04:28 PM
Popovits Kimberly JPresident and CEOJul 16Option Exercise17.1810,000171,800246,157Jul 18 04:40 PM
Popovits Kimberly JPresident and CEOJul 16Sale53.2710,000532,684236,157Jul 18 04:40 PM
Shak StevenChief Scientific OfficerJul 09Option Exercise17.335,50095,315341,416Jul 10 05:18 PM
Shak StevenChief Scientific OfficerJul 09Sale49.565,500272,554335,916Jul 10 05:18 PM
Popovits Kimberly JPresident and CEOJun 14Option Exercise17.1810,000171,800246,157Jun 18 07:16 PM
Popovits Kimberly JPresident and CEOJun 14Sale48.8910,000488,916236,157Jun 18 07:16 PM
Shak StevenChief Scientific OfficerJun 11Option Exercise17.335,50095,315341,416Jun 13 06:59 PM
Shak StevenChief Scientific OfficerJun 11Sale50.225,500276,200335,916Jun 13 06:59 PM
Vaughn James JChief Commercial OfficerJun 04Option Exercise25.9880,7682,097,99749,655Jun 06 07:57 PM
Vaughn James JChief Commercial OfficerJun 04Sale45.7893,4144,276,16517,009Jun 06 07:57 PM
Popovits Kimberly JPresident and CEOMay 14Option Exercise17.1810,000171,800246,157May 16 06:41 PM
Popovits Kimberly JPresident and CEOMay 14Sale38.0910,000380,877236,157May 16 06:41 PM
Shak StevenChief Scientific OfficerMay 09Option Exercise17.335,50095,315341,416May 11 03:10 PM
Shak StevenChief Scientific OfficerMay 09Sale36.645,500201,543335,916May 11 03:10 PM
Vaughn James JChief Commercial OfficerMay 02Sale32.501,49748,65329,655May 04 08:59 PM
Popovits Kimberly JPresident and CEOApr 16Option Exercise17.1815,000257,700251,157Apr 18 04:33 PM
Popovits Kimberly JPresident and CEOApr 16Sale33.1915,000497,880236,157Apr 18 04:33 PM
Popovits Kimberly JPresident and CEOMar 14Option Exercise17.185,00085,900241,157Mar 16 06:54 PM
Popovits Kimberly JPresident and CEOMar 14Sale32.015,000160,048236,157Mar 16 06:54 PM
Cole G BradleyCOOMar 13Option Exercise17.335,00086,65049,754Mar 15 04:31 PM
Cole G BradleyCOOMar 13Sale32.805,000164,01444,754Mar 15 04:31 PM
BAKER BROS. ADVISORS LPDirectorMar 09Option Exercise18.5049,500915,75011,369,282Mar 12 06:04 PM
Cole G BradleyCOOFeb 20Option Exercise17.335,00086,65049,754Feb 22 04:19 PM
Febbo Phillip G.Chief Medical OfficerFeb 20Sale32.844,942162,29021,387Feb 22 04:19 PM
Cole G BradleyCOOFeb 20Sale32.895,000164,47444,754Feb 22 04:19 PM
Leber LauraChief Communication OfficerFeb 20Sale32.923,374111,08016,531Feb 22 04:24 PM
Popovits Kimberly JPresident and CEOFeb 14Option Exercise17.1810,000171,80075,849Feb 15 04:02 PM
Popovits Kimberly JPresident and CEOFeb 14Sale32.9310,000329,33665,849Feb 15 04:02 PM
Popovits Kimberly JPresident and CEOJan 16Option Exercise17.1810,000171,80051,719Jan 18 09:30 PM
Popovits Kimberly JPresident and CEOJan 16Sale34.9910,000349,88541,919Jan 18 09:30 PM
Cole G BradleyCOOJan 09Option Exercise17.335,00086,65045,346Jan 10 09:17 PM
Cole G BradleyCOOJan 09Sale35.515,000177,56640,346Jan 10 09:17 PM
Vaughn James JChief Commercial OfficerJan 02Option Exercise17.332,16937,58930,481Jan 04 07:54 PM
Vaughn James JChief Commercial OfficerJan 02Sale34.093,004102,40627,477Jan 04 07:54 PM
Febbo Phillip G.Chief Medical OfficerDec 19Option Exercise27.005,000135,00023,134Dec 20 04:35 PM
Febbo Phillip G.Chief Medical OfficerDec 19Sale36.995,334197,29817,800Dec 20 04:35 PM
Leber LauraChief Communication OfficerDec 15Option Exercise17.339,000155,97024,754Dec 18 07:52 PM
Leber LauraChief Communication OfficerDec 15Sale35.009,000315,00015,754Dec 18 07:52 PM
Popovits Kimberly JPresident and CEODec 14Option Exercise17.2820,000345,53561,919Dec 18 07:51 PM
Leber LauraChief Communication OfficerDec 14Option Exercise21.5212,000258,24027,754Dec 18 07:52 PM
Leber LauraChief Communication OfficerDec 14Sale32.0012,000384,00015,754Dec 18 07:52 PM
Popovits Kimberly JPresident and CEODec 14Sale31.5020,000630,00041,919Dec 18 07:51 PM
Cole G BradleyCOODec 12Option Exercise17.335,00086,65044,935Dec 13 04:14 PM
Cole G BradleyCOODec 12Sale29.945,000149,70939,935Dec 13 04:14 PM
Cole G BradleyCOONov 07Option Exercise17.335,00086,65044,935Nov 09 04:59 PM
Cole G BradleyCOONov 07Sale31.475,000157,33039,935Nov 09 04:59 PM
Vaughn James JChief Commercial OfficerNov 02Option Exercise17.3392416,01328,999Nov 08 05:29 PM
Vaughn James JChief Commercial OfficerNov 02Sale32.511,37944,82727,620Nov 08 05:29 PM
Vaughn James JChief Commercial OfficerNov 01Option Exercise17.333,90767,70833,692Nov 08 05:29 PM
Vaughn James JChief Commercial OfficerNov 01Sale32.585,617183,00128,075Nov 08 05:29 PM
Cole G BradleyCOOOct 10Option Exercise17.335,00086,65044,935Oct 11 05:55 PM
Cole G BradleyCOOOct 10Sale31.935,000159,63739,935Oct 11 05:55 PM
Popovits Kimberly JPresident and CEOSep 14Option Exercise17.335,00086,65046,132Sep 18 04:02 PM
Popovits Kimberly JPresident and CEOSep 14Sale31.005,000154,98941,132Sep 18 04:02 PM
Cole G BradleyCOOSep 12Option Exercise17.335,00086,65044,935Sep 14 05:12 PM
Cole G BradleyCOOSep 12Sale31.865,000159,28839,935Sep 14 05:12 PM